Found 816 results
Fields J, Dumaop W, Eleuteri S, Elueteri S, Campos S, Serger E, Trejo M, Kosberg K, Adame A, Spencer B, et al. HIV-1 Tat alters neuronal autophagy by modulating autophagosome fusion to the lysosome: implications for HIV-associated neurocognitive disorders. J Neurosci. 2015 ;35(5):1921-38.
Zenón F, Cantres-Rosario Y, Adiga R, Gonzalez M, Rodriguez-Franco E, Langford D, Meléndez LM. HIV-infected microglia mediate cathepsin B-induced neurotoxicity. J Neurovirol. 2015 ;21(5):544-58.
Haley SA, O’Hara B, Nelson CDS, Brittingham FLP, Henriksen KJ, Stopa EG, Atwood WJ. Human polyomavirus receptor distribution in brain parenchyma contrasts with receptor distribution in kidney and choroid plexus. Am J Pathol. 2015 ;185(8):2246-58.
Suh H-S, Lo Y, Choi N, Letendre S, Lee SC. Insulin-like growth factors and related proteins in plasma and cerebrospinal fluids of HIV-positive individuals. J. Neuroinflammation. 2015 ;12.
Cantres-Rosario Y, Hernandez N, Negron K, Perez-Laspiur J, Leszyk J, Shaffer SA, Meléndez LM. Interacting partners of macrophage-secreted cathepsin B contribute to HIV-induced neuronal apoptosis. AIDS. 2015 ;29(16):2081-92.
Williams DW, Anastos K, Morgello S, Berman JW. JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals. J Leukoc Biol. 2015 ;97(2):401-12.
Wüthrich C, Batson S, Koralnik IJ. Lack of Major Histocompatibility Complex Class I Upregulation and Restrictive Infection by JC Virus Hamper Detection of Neurons by T Lymphocytes in the Central Nervous System. J Neuropathol Exp Neurol. 2015 ;74(8):791-803.
Fields J, Dumaop W, Crews LA, Adame A, Spencer B, Metcalf J, He JJ, Rockenstein E, Masliah E. Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders. Curr HIV Res. 2015 ;13(1):43-54.
Levine AJ, Soontornniyomkij V, Achim C, Masliah E, Gelman B, Sinsheimer JS, Singer EJ, Moore DJ. Multilevel analysis of neuropathogenesis of neurocognitive impairment in HIV. Journal of NeuroVirology. Journal of Neurovirology. 2015 .
Cserhati MF, Pandey S, Beaudoin JJ, Baccaglini L, Guda C, Fox HS. The National NeuroAIDS Tissue Consortium (NNTC) Database: an integrated database for HIV-related studies. Database (Oxford). 2015 ;2015:bav074.
Morgan EE, Iudicello JE, Cattie JE, Blackstone K, Grant I, Woods SPaul. Neurocognitive impairment is associated with lower health literacy among persons living with HIV infection. AIDS Behav. 2015 ;19(1):166-77.
Thames AD, Castellon SA, Singer EJ, Nagarajan R, Sarma MK, Smith J, Thaler NS, Truong JHien, Schonfeld D, M Thomas A, et al. Neuroimaging abnormalities, neurocognitive function, and fatigue in patients with hepatitis C. Neurol Neuroimmunol Neuroinflamm. 2015 ;2(1):e59.
Kim WJ, Zekas E, Lodge R, Susan-Resiga D, Marcinkiewicz E, Essalmani R, Mihara K, Ramachandran R, Asahchop EL, Gelman B, et al. Neuroinflammation-Induced Interactions between Protease-Activated Receptor 1 and Proprotein Convertases in HIV-Associated Neurocognitive Disorder. Mol Cell Biol. 2015 ;35(21):3684-700.
Robinson-Papp J, Sharma S, Dhadwal N, Simpson DM, Morgello S. Optimizing measures of HIV-associated neuropathy. Muscle Nerve. 2015 ;51(1):56-64.
Gutierrez J, Elkind MSV, Virmani R, Goldman JE, Honig L, Morgello S, Marshall RS. A pathological perspective on the natural history of cerebral atherosclerosis. Int J Stroke. 2015 ;10(7):1074-80.
Arrildt KT, LaBranche CC, Joseph SB, Dukhovlinova EN, Graham WD, Ping L-H, Schnell G, Sturdevant CB, Kincer LP, Mallewa M, et al. Phenotypic Correlates of HIV-1 Macrophage Tropism Sandri-Goldin RM. Journal of Virology [Internet]. 2015 ;89(22):11294 - 11311. Available from:
Fazeli PL, Marquine MJ, Dufour C, Henry BL, Montoya J, Gouaux B, Moore RC, Letendre S, Woods SPaul, Grant I, et al. Physical Activity is Associated with Better Neurocognitive and Everyday Functioning Among Older Adults with HIV Disease. AIDS Behav. 2015 ;19(8):1470-7.
Anderson AM, Harezlak J, Bharti AR, Mi D, Taylor MJ, Daar ES, Schifitto G, Zhong J, Alger JR, Brown MS, et al. Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2015 ;69(1):29-35.
Fellows RP, Spahr NA, Byrd D, Rivera-Mindt M, Morgello S. Psychological trauma exposure and co-morbid psychopathologies in HIV+ men and women. Psychiatry Research . 2015 .
Olsen J, Fellows RP, Rivera-Mindt M, Morgello S, Byrd D. Reading ability as an estimator of premorbid intelligence: Does it remain stable among ethnically diverse HIV+ adults?. The Clinical Neuropsychologist. 2015 .
Thames AD, Briones MS, Magpantay LI, Martínez-Maza O, Singer EJ, Hinkin CH, Morgello S, Gelman B, Moore DJ, Heizerling K, et al. The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients. AIDS. 2015 ;29(12):1483-91.
Yang L, Yao H, Chen X, Cai Y, Callen S, Buch S. Role of Sigma Receptor in Cocaine-Mediated Induction of Glial Fibrillary Acidic Protein: Implications for HAND. Mol Neurobiol. 2015 .
Arentoft A, Byrd D, Monzones J, Coulehan K, Fuentes A, Rosario A, Miranda C, Morgello S, Rivera-Mindt M. Socioeconomic status and neuropsychological functioning: Associations in an ethnically diverse HIV+ cohort. Clinical Neuropsychology. 2015 ;29(2):232-254.
Brown A. Understanding the MIND phenotype: macrophage/microglia inflammation in neurocognitive disorders related to human immunodeficiency virus infection. [Internet]. 2015 ;4(1):7. Available from:
Alraaba SF, Somboonwit C, Shapshak P, Kuhn J, Sinnott JT. West Nile Virus in Global Virology I. Identifying and investigating viral diseases. In: Global Virology I. Identifying and investigating viral diseases. Global Virology I. Identifying and investigating viral diseases. New York: Springer Publ.; 2015.